SUMO2 and cancer: For this reason, SUMO2, SUMO3 and SUMO4 can be potentially exploited in further anti-cancer mechanisms investigations (p-value = 0.024 in the present study), in order to shed light on the regulatory mechanisms underlying the activity of SUMO machinery in an oncogenic framework.